BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31352437)

  • 1. Aberrant DNA methylation of synaptophysin is involved in adrenal cortisol-producing adenoma.
    Zhong JY; Cui RR; Lin X; Xu F; Zhu T; Li F; Wu F; Zhou E; Yi L; Yuan LQ
    Aging (Albany NY); 2019 Jul; 11(14):5232-5245. PubMed ID: 31352437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.
    Perge P; Decmann Á; Pezzani R; Bancos I; Fassina A; Luconi M; Canu L; Tóth M; Boscaro M; Patócs A; Igaz P
    Endocrine; 2018 Feb; 59(2):280-287. PubMed ID: 29299796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of DNA methylation with steroidogenic enzymes in Cushing's adenoma.
    Kodama T; Oki K; Otagaki Y; Baba R; Okada A; Itcho K; Kobuke K; Nagano G; Ohno H; Hinata N; Arihiro K; Gomez-Sanchez CE; Yoneda M; Hattori N
    Endocr Relat Cancer; 2022 Aug; 29(8):495-502. PubMed ID: 35675123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.
    Velázquez-Fernández D; Caramuta S; Özata DM; Lu M; Höög A; Bäckdahl M; Larsson C; Lui WO; Zedenius J
    Eur J Endocrinol; 2014 Apr; 170(4):583-91. PubMed ID: 24446485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of steroidogenic enzymes and their transcription factors in cortisol-producing adrenocortical adenomas: immunohistochemical analysis and quantitative real-time polymerase chain reaction studies.
    Kubota-Nakayama F; Nakamura Y; Konosu-Fukaya S; Azmahani A; Ise K; Yamazaki Y; Kitawaki Y; Felizola SJ; Ono Y; Omata K; Morimoto R; Iwama N; Satoh F; Sasano H
    Hum Pathol; 2016 Aug; 54():165-73. PubMed ID: 27085553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous circulating miRNA profiles of PBMAH.
    Hara K; Murakami M; Niitsu Y; Takeuchi A; Horino M; Shiba K; Tsujimoto K; Komiya C; Ikeda K; Tsuiki M; Tanabe A; Tanaka T; Yokoyama M; Fujii Y; Naruse M; Yamada T
    Front Endocrinol (Lausanne); 2022; 13():1073328. PubMed ID: 36583003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma.
    Kitawaki Y; Nakamura Y; Kubota-Nakayama F; Yamazaki Y; Miki Y; Hata S; Ise K; Kikuchi K; Morimoto R; Satoh F; Sasano H
    Hum Pathol; 2018 Jul; 77():88-97. PubMed ID: 29596893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
    Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J
    Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicine. A unified cause for adrenal Cushing's syndrome.
    Kirschner LS
    Science; 2014 May; 344(6186):804-5. PubMed ID: 24855241
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.
    Giordano TJ
    Nat Rev Endocrinol; 2014 Aug; 10(8):447-8. PubMed ID: 24913521
    [No Abstract]   [Full Text] [Related]  

  • 11. In Situ Metabolomics of Cortisol-Producing Adenomas.
    Murakami M; Sun N; Li F; Feuchtinger A; Gomez-Sanchez C; Fassnacht M; Reincke M; Bancos I; Walch A; Kroiss M; Beuschlein F
    Clin Chem; 2023 Feb; 69(2):149-159. PubMed ID: 36544353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics.
    Sargent J
    Nat Rev Endocrinol; 2014 Jun; 10(6):311. PubMed ID: 24751881
    [No Abstract]   [Full Text] [Related]  

  • 13. Synaptophysin immunoreactivity in adrenocortical adenomas: a correlation between synaptophysin and CYP17A1 expression.
    Shigematsu K; Nishida N; Sakai H; Igawa T; Toriyama K; Nakatani A; Takahara O; Kawai K
    Eur J Endocrinol; 2009 Dec; 161(6):939-45. PubMed ID: 19755404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
    Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
    Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
    Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Myxoma Caused by Fumarate Hydratase Gene Deletion in Patient With Cortisol-Secreting Adrenocortical Adenoma.
    Suda K; Fukuoka H; Yamazaki Y; Shigemura K; Mukai M; Odake Y; Matsumoto R; Bando H; Takahashi M; Iguchi G; Fujisawa M; Oka M; Ono K; Chihara K; Sasano H; Ogawa W; Takahashi Y
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32249909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
    Yamada M; Nakajima Y; Taguchi R; Okamura T; Ishii S; Tomaru T; Ozawa A; Shibusawa N; Yoshino S; Toki A; Ishida E; Hashimoto K; Satoh T; Mori M
    Endocr J; 2012; 59(8):735-41. PubMed ID: 22863749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTH-induced cortisol secretion is mediated by cAMP and PKC in various adrenocortical adenomas.
    Ishizuka T; Daidoh H; Morita H; Mune T; Miura A; Suwa T; Shibata T; Yamada K; Itaya S; Kajita K; Yasuda K
    Endocr J; 1997 Oct; 44(5):661-70. PubMed ID: 9466321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
    Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.